![Andrea Pederzolli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea Pederzolli
Presidente en
Laboratori Italiani Riuniti SpA
.
Perfil
Andrea Pederzolli is currently the Chairman at Laboratori Italiani Riuniti SpA since 2020.
Prior to this, he worked as a Fund Manager at Xyence Capital SGR from 2017 to 2021 and as a Director at Enterome SA.
Cargos activos de Andrea Pederzolli
| Empresas | Cargo | Inicio |
|---|---|---|
Laboratori Italiani Riuniti SpA
 Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Presidente | 01/02/2020 |
Antiguos cargos conocidos de Andrea Pederzolli.
| Empresas | Cargo | Fin |
|---|---|---|
Xyence Capital SGR SpA
 Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Inversor de Capital Privado | 01/05/2021 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
8
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Xyence Capital SGR SpA
Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Finance |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
Laboratori Italiani Riuniti SpA
Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Commercial Services |
- Bolsa de valores
- Insiders
- Andrea Pederzolli
